Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsNish Chaturvedi, Anne Katrin Sjølie, John Fuller et al.|The Lancet|2008Cited by 450
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAnne Katrin Sjølie, Nish Chaturvedi, Ronald Klein et al.|The Lancet|2008Cited by 432